Cost Effectiveness and Resource Allocation

Papers
(The H4-Index of Cost Effectiveness and Resource Allocation is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Cost-effectiveness of cardiac resynchronization therapy plus an implantable cardioverter-defibrillator in patients with heart failure: a systematic review42
Vaccination distribution by community pharmacists under the COVID-19 vaccine appointment system in Taiwan28
Quantifying the direct cost benefits of vestibular telemetry using the CAVA system to diagnose the causes of dizziness28
Cost-effectiveness of implant movement analysis in aseptic loosening after hip replacement: a health-economic model27
The use of cost-effectiveness analysis for health benefit package design – should countries follow a sectoral, incremental or hybrid approach?25
Developing and validating a multi-criteria decision analytic tool to assess the value of cancer clinical trials: evaluating cancer clinical trial value24
Systematic review of the evidence sources applied to cost-effectiveness analyses for older women with primary breast cancer23
Comparative effectiveness and cost evaluation of Risankizumab and Adalimumab in the management of psoriasis: a real-world study in Saudi Arabia22
A cost-effectiveness analysis of the combination of serplulimab with chemotherapy for advanced esophageal squamous cell carcinoma: insights from the ASTRUM-007 trial20
Cost-effectiveness of sacituzumab govitecan versus single-agent chemotherapy for metastatic triple-negative breast cancer: a trial-based analysis20
Cost-effectiveness analysis of coronary arteries bypass grafting (CABG) and percutaneous coronary intervention (PCI) through drug stent in iran: a comparative study20
Economic burden of knee joint replacement in Iran19
Comparison of current relative value unit-based prices and utility between common surgical procedures, including orthopedic surgeries, in South Korea18
Third-line multiple myeloma treatment of inpatients in a German cancer center: analysis of potential cost savings due to decreased renal insufficiency17
Use of real-world evidence to support regulatory decisions on medical devices in China and a unique opportunity to gain accelerated approval in “Boao Lecheng Pilot Zone”17
Factor associated with willingness to pay for prevention of cancer: a study of prostate cancer screening17
Willingness to pay for cataract surgery and its associated factors in selected medical centers in Urmia, Iran16
0.056696891784668